User:Mr. Ibrahem/Omacetaxine

Omacetaxine, sold under the brand name Synribo, is a medication used to treat chronic myeloid leukemia (CML). It is used in cases were other medications have not worked. It is given by injection under the skin.

Common side effects include low platelets, low red blood cells, low white blood cells, fever, diarrhea, nausea, and pain. Other side effects may include bleeding and infection. Use during pregnancy may harm the baby. It is a protein synthesis inhibitor.

Omacetaxine was approved for medical use in the United States in 2012. It is not approved in Europe. In the United States it costs about 1,200 USD for 3.5 mg as of 2021. It is made from a substance in the Chinese evergreen known as harringtonine.